To buy Customized Research reports, please email: suhani.adilabadkar@gmail.com or call: 9701063320

Saturday, 27 August 2016

OASIS FUNDAMENTALS - WEEKLY UPDATE


PARTING GIFT FROM DR. RAJAN

Bond markets got a booster shoot from RBI with slew of measures announced on 25th August 2016. Accepting Khan Committee Report recommendations, RBI has announced various measures ranging from enhancing aggregate limit of partial credit enhancement (PCE) provided by banks, permit brokers in corporate bond repos, authorize platform for repo in corporate bonds and encouraging credit supply for large borrowers through market mechanism. The central bank will also seek amendments in the RBI Act to accept corporate bonds under Liquidity adjustment Facility (LAF). In addition to this, banks would be permitted to issue Masala Bonds i.e Rupee bonds overseas for their capital requirements and for financing infrastructure and affordable housing. The RBI has also announced that Foreign Portfolio Investors (FPIs) would be given direct access to NDS-OM and trade directly in corporate bonds.

For forex markets, Reserve Bank has now permitted entities both resident/non-resident to hedge transactions upto a limit of USD 30 million at any given time. The entity would be free to access any market, OTC or any other exchange and use any of the permissible products at its discretion In addition to this limit, AD banks based on their assessment of the customer, may allow an open position limit of upto USD 5 million. 

JANET &  JACKSON HOLE

US Fed has signaled that the US economy is on a strong footing with respect to labor market though inflation is still under 2%. Incase August jobs report next Friday is positive, likelihood of September hike cannot be ruled out. But December rate hike is higher possibility with US elections in November. 

INFOSYS SYNDROME


Infosys touched its 52 week low during the week and closed at Rs. 1020.75 on Friday. The Bengaluru based company clarified that it would give more accurate information on its revenue guidance after the second quarter FY17. The company is reeling under Brexit effects among its clients. The Royal Bank of Scotland has cancelled its contract with the company post Brexit.      

Friday, 26 August 2016

FRIDAY - Daily Market Wrap Up


Highlights of the Day

  •  Abbott India reported strong performance with 10% rise in Net Profit & 16% jump in income from operations for the quarter ended 30th June 2016. The stock was up 0.62% and closed at Rs. 4731.45.
  •   J.B. Chemicals & Pharmaceuticals Ltd was one of the star performers rising 8% and closing at Rs. 366.60 gaining Rs.24.65 by the end of the day. The company reported 26% rise in its standalone Net Profit and 9% increase in income from operations in June quarter.
  •  Finolex cables reported 37% rise in Net Profit for the period ended June 30th 2016. The stock closed at Rs. 428.65 by end of the day. 
  • Finolex Industries also reported strong quarterly performance with 36% rise in PAT and 6% jump in income from operations.
  •  Nifty declined 0.23% at 8572.55 for the day with 21 advances and 30 declines. S&P BSE 30 closed down by 0.19% at 27782.25 declining by 53.66 points for the da

Major Developments  


Biocon Ltd has announced regulatory submission for proposed biosimilar trastuzumab acccepted for review by European Medicines Agency".


Market Mood   
              
Stock markets ended flat with midcaps outperforming on both S&P BSE & NSE. S&P Midcap rose 0.21% gaining 22.21 points whereas Nifty Midcap 50 jumped 0.34% by the end of the day. Nifty Auto was another out-performer rising 0.71% for the day. For the week as a whole S&P BSE Sensex and Nifty closed down by 0.9% and 1% respectively.   

                                  


Wednesday, 24 August 2016

Wednesday – Daily Market Wrap Up

Highlights of the Day
  • Engineers India reported stellar performance with 50% rise in Net Profit for the quarter ended 30th June 2016. The stock was up 8.16% and closed at Rs. 251.
  •  Aurobindo Pharma Ltd also enthralled stock markets with 24% rise in its consolidated Net Profit and 13% rise in income from operations in Q1 FY17. The scrip closed at Rs. 787.55 or 7% up by the end of the day.
  •   Vardhaman Textiles reported 4% rise in Net Profit for the period ended June 30th 2016. The stock gained Rs. 44.35 to close at Rs. 1024.45 or 4.53% up by end of the day.
  • Nifty closed 0.21% up at 8650.30 for the day with 24 advances and 27 declines. S&P BSE 30 closed at 28059.94 up 0.25% or 69.73 points for the day.

Major Developments                          

  •     Central government has cleared the revised double taxation avoidance agreement (DTAA) with Cyprus. The agreement will allow India to tax capital gains from April 1 2017.
  • Citibank is in initial stages of launching the largest digital contract of USD 1 billion. The contract is for end-to-end transformation of the company’s global operations.


Market Mood   

Stock markets were range-bound with small and midcaps stealing the show. S&P BSE Mid & Small cap were up by 0.61% and 0.65% respectively.


HDFC BANK Q1 FY 17 REPORT


Banking Industry bell-weather, HDFC Bank reported strong first quarter results with Net Profit, Net Interest Income, deposits and advances rising in double digits. The second largest private sector bank with CAR of 15.50% (Tier I-13.30%) commands credibility due to growing profitability and stable asset quality in today’s volatile scenario. The bank is poised for higher growth as one of the major players in Indian banking industry. Thus we recommend BUY for the stock for medium and long term investment. Read the full report below...



                                  Tuesday Tantrums – Daily Market Wrap Up    

Highlights of the Day
  •   IPO of RBL Bank has been over subscribed 69.53 times on the last day of the issue. The price band of the offer was RS.224-225 per share. The IPO received bids for 263.52 crore equity shares against the total issue size of 3.79 crore shares.
  •  Gillette announced June quarter results with profit declining by 35%. The scrip ended 1.71% down at Rs. 4681.40.
  •  Tata Power announced June quarter with net profit declining by 63%. The scrip closed down by 3.24% at RS.74.75 at the end of the day.
  • Nifty closed 0.04% up at 8632.60 for the day with 24 advances and 27 declines. S&P BSE 30 closed at 27990.21 up 0.02% or 4.67 points for the day.

Market Rumours
Idea and Vodafone are in talks for a mega merger or a strategic deal. The merger if it happens would dislodge Bharti Airtel from its number one position. Vodafone would also get automatic listing after the merger. Both the companies denied the merger news.

Market Mood                 

Both the major indices were volatile and recovered late in the day. IT stocks helped in the recovery as Nifty IT was up by 1.64%. Infosys led the IT pack rising by 2.41%. 

Monday, 22 August 2016

                         Monday Blues - Daily Market Wrap Up

Highlights of the Day

  • IPO of RBL Bank has been fully subscribed on the second day of the issue. The price band of the offer is RS.224-225 per share. The offer would close tomorrow. 
  •  NTPC announced Q1 FY17 results with profit rising by 4% and income from operations growing 11% YOY.
  • Hindustan Copper announced Q1 FY17 with a net loss of Rs. (28.80) million for the quarter ended June 30, 2016 as compared to net profit of Rs. 200 million for the quarter ended June 30, 2015.
  • Pharmaceutical Major Lupin Limited (Lupin) has received approval for Acotiamide 100 mg Tablets from the Central Drugs Standard Control Organisation (CDSCO).
  • Nifty closed 0.44% down at 8629.15 for the day with 15 advances and 36 declines. S&P BSE 30 closed down 0.33% or 91.46 points at 27985.54 for the da
Company Update

Lupin Limited
Lupin Limited (Lupin) has received approval for Acotiamide 100 mg Tablets from the Central Drugs Standard Control Organisation (CDSCO). Acotiamide is a first-in-class novel drug to be introduced into the Indian Pharmaceutical Market (IPM) which could benefit millions of patients suffering from Dyspepsia or Indigestion, amongst the most common stomach complaints encountered in clinical practice. The current market for plain Gastrointestinal (GI) prokinetics and combinations is estimated to be around INR 2640 crores growing at 14%. The overall GI market is estimated at INR 11,438 crores which is growing at 13%.

Market Mood             
    
Both the major indices moved southwards with Infosys hitting 52 week low. Caution and profit booking was the flavor of the day. Banking industry welcomed the appointment of Dr. Urjit Patel as the new RBI Governor whereas stock markets seemed to loose hope of a rate cut with bank nifty closing 0.43% down.
                             


Thursday, 18 August 2016

POWER GRID CORPORATION OF INDIA Q1 FY17 REPORT Power Grid Corporation Of India reported strong first quarter results FY17 with both Revenue/Income from operations and PAT growing by 30% & 33% YOY respectively.The company has prepared its financial statements in the current quarter on the basis of Indian Accounting Standards. In the present scenario with government reforms giving huge fillip to power & infrastructure, Electric Utilities sector stands to gain in the long run. Thus we are bullish on the stock for medium and long term. Read the full report below.

Thursday, 11 August 2016

YES BANK research report Q1 FY 17 In the present volatile scenario with liquidity churning stock markets, Yes Bank is one of the best bets available in the current Indian Banking scenario. We recommend BUY for the stock for medium and long term. Read the entire report below...

Thursday, 4 August 2016

IndusInd Bank Research Report

IndusInd bank with CAR of 15.42% (Tier I-14.81%), credit growth rate above industry average, growing profitability and stable asset quality is poised for high growth as one of the major players in Indian banking industry. Thus we recommend BUY for the stock for medium and long term investment.

Read the entire Report Here.


Wednesday, 3 August 2016

INDUSIND BANK: Q1 FY17

Yet, another Blockbuster performance by IndusInd Bank, one of the leading star performers of Indian private banking sector. IndusInd has become synonymous with double digit growth. As expected, Net Profit, Net Interest Income, deposits and advances all reported double digit growth rates. Net Interest Income, difference between interest earned and expended was at Rs. 13564 mn up by 38% YOY. Net Profit too zoomed 26% YOY at Rs.6614 mn in the current June quarter. Net Interest Margin at 3.97% completed the picture with 29 basis points jump buttressing the bank’s profitability in the present volatile scenario. Asset quality is stable with Gross NPAs and Net NPAs at 0.91% and 0.38%, rising by 4 bp and 2 bp respectively QOQ. Provisions & contingencies have risen considerably, 8% QOQ and almost doubled to Rs. 2305 mn compared to corresponding period previous year. Double digit growth rate is visible in all business segments except treasury, retail segment (23%) which constitutes 51% of the total revenue followed by other banking business (31%) and corporate (18%). Low cost funding CASA declined by 30 basis points YOY in the present June quarter which is a concern area for the bank. Other income which accounts for 23% of the total income for the bank climbed 28% YOY in Q1 FY17. Growth momentum continued for core fee with yearly growth of 23%. Deposits and Advances grew parallely at 30% growth rate YOY in Q1 FY17. Unpredictable Fed moves, China & Europe slowdown and now Brexit has kept equity investors on tenterhooks. Thus with uncertainty being the new norm, Indian Private sector offers ray of hope for value investors.  IndusInd bank with CAR of 15.42% (Tier I-14.81%), credit growth rate above industry average, growing profitability and stable asset quality is poised for high growth as one of the major players in Indian banking industry. Thus ‘BUY’ signal is recommended for the stock with the target price of Rs.1280 for medium and long term investment.  

Disclaimer

The information and opinions contained in the research reports have been compiled or arrived at from sources believed reliable but no representation or warranty, express or implied, is made as to their accuracy or completeness. The research report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Clients should consider whether any advice or recommendation in this research is suitable for their particular circumstances and, if appropriate, seek professional advice, including but not limited to tax advice. The reports do not take into account the particular investment objectives, financial situations, risk profile or needs of individual clients. The user assumes the entire risk of any use made of this information. This report is not to be relied upon in substitution for the exercise of independent judgment.

The price and value of investments referred to in this research and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur.

Research data and reports published/ emailed/ text messaged via Short Messaging Services, Online Messengers, WhatsApp etc/transmitted through mobile application/s, including but not limited to FLIP™, Video Widget, telephony networks, print or electronic media and or those made available/uploaded on social networking sites (e.g. Facebook, Twitter, LinkedIn etc) is for informational purposes only. The reports are provided for assistance and are not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Though disseminated to clients simultaneously, not all clients may receive the reports at the same time. We will not treat recipients as clients by virtue of their receiving this report.

The reports include projections, forecasts and other predictive statements which represent our assumptions and expectations in the light of currently available information. These projections and forecasts are based on industry trends, circumstances and factors which involve risks, variables and uncertainties. The actual performance of the companies represented in the report may vary from those projected.

The opinions expressed in the reports are subject to change but we have no obligation to tell our clients when our opinions or recommendations change. The reports are non-inclusive and do not consider all the information that the recipients may consider material to investments.

We shall not be in any way responsible for any indirect, special or consequential damages that may arise to any person from any inadvertent error in the information contained in the reports nor do they take guarantee or assume liability for any omissions of the information contained therein. Information contained therein cannot be the basis for any claim, demand or cause of action. These data, reports and information do not constitute scientific publication and do not carry any evidentiary value whatsoever.

The user should consult their own advisors to determine the merits and risks of investment and also read the Risk Disclosure Documents for Capital Markets and Derivative Segments as prescribed by Securities and Exchange Board of India before investing in the Indian Markets. The securities discussed in this report may not be suitable for all investors. Investors must make their own investment decision based on their own investment objectives, goals and financial position and based on their own analysis. Prospective investors and others are cautioned that any forward-looking statements, if any, are not predictions and may be subject to change without notice.

This report may provide the addresses of, or contain hyperlinks to websites. Except to the extent to which the report refers to material we take no responsibility whatsoever for the contents therein. Such addresses or hyperlinks are provided solely for your convenience and information and the content of the linked site does not in any way form part of this report. Accessing such website or following such link through this report shall be at your own risk.

The author of this Research Report accepts no liability and will not in any way be responsible for the contents of this report or for any losses, costs, expenses, charges, including notional losses/lost opportunities incurred by a recipient as a result of acting or non-acting on any information/material contained in the report. This is not an offer to sell or a solicitation to buy any securities or an attempt to influence the opinion or behavior of investors or recipients or provide any investment/tax advice. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.